Aantal gebruikers 2018-2022 voor ATC-subgroep C09CA : Angiotensine-ii-antagonisten
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| C09CA01 Losartan (Cozaar ®) | 313.960 | 360.970 | 324.800 | 325.330 | 330.300 |
| C09CA02 Eprosartan (Teveten ®) | 2.533 | 1.735 | 349 | 371 | 365 |
| C09CA03 Valsartan (Diovan ®) | 182.790 | 54.300 | 47.511 | 55.031 | 63.456 |
| C09CA04 Irbesartan (Aprovel ®) | 150.050 | 156.950 | 149.210 | 147.980 | 145.730 |
| C09CA06 Candesartan (Atacand ®) | 107.300 | 125.410 | 124.430 | 131.900 | 139.320 |
| C09CA07 Telmisartan (Micardis ®) | 46.937 | 54.482 | 51.470 | 52.296 | 53.292 |
| C09CA08 Olmesartan (Olmetec ®) | 15.187 | 16.265 | 16.575 | 16.933 | 16.702 |